Adarza BioSystems Receives $4,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e12896e4-5d53-448e-a267-6c49388519e0 - Date
10/3/2014 - Company Name
Adarza BioSystems - Mailing Address
150 Lucius Gordon Dr. West Henrietta, NY 14586 USA - Company Description
Adarza BioSystems, Inc is an early stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. This technology is fully arrayable, potentially allowing hundreds of tests to be run simultaneously on a single chip. - Website
http://www.adarzabio.com - Transaction Type
Venture Equity - Transaction Amount
$4,000,000 - Transaction Round
Series A - Proceeds Purposes
The latest financing is being used to launch the company’s first 100-plex immunoassay product and accelerate development of highly sensitive plex assays that target biological analytes. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
